Cargando…

(PO-069) A Case of Post-COVID Catatonia Partially Refractory to IV Lorazepam

Detalles Bibliográficos
Autores principales: Rodulfo, Alejandro, Hagerty, Vivian, Sotelo, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296179/
http://dx.doi.org/10.1016/j.jaclp.2022.03.073
_version_ 1784750214222970880
author Rodulfo, Alejandro
Hagerty, Vivian
Sotelo, Jorge
author_facet Rodulfo, Alejandro
Hagerty, Vivian
Sotelo, Jorge
author_sort Rodulfo, Alejandro
collection PubMed
description
format Online
Article
Text
id pubmed-9296179
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92961792022-07-20 (PO-069) A Case of Post-COVID Catatonia Partially Refractory to IV Lorazepam Rodulfo, Alejandro Hagerty, Vivian Sotelo, Jorge J Acad Consult Liaison Psychiatry Article Published by Elsevier Inc. 2022 2022-07-19 /pmc/articles/PMC9296179/ http://dx.doi.org/10.1016/j.jaclp.2022.03.073 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Rodulfo, Alejandro
Hagerty, Vivian
Sotelo, Jorge
(PO-069) A Case of Post-COVID Catatonia Partially Refractory to IV Lorazepam
title (PO-069) A Case of Post-COVID Catatonia Partially Refractory to IV Lorazepam
title_full (PO-069) A Case of Post-COVID Catatonia Partially Refractory to IV Lorazepam
title_fullStr (PO-069) A Case of Post-COVID Catatonia Partially Refractory to IV Lorazepam
title_full_unstemmed (PO-069) A Case of Post-COVID Catatonia Partially Refractory to IV Lorazepam
title_short (PO-069) A Case of Post-COVID Catatonia Partially Refractory to IV Lorazepam
title_sort (po-069) a case of post-covid catatonia partially refractory to iv lorazepam
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296179/
http://dx.doi.org/10.1016/j.jaclp.2022.03.073
work_keys_str_mv AT rodulfoalejandro po069acaseofpostcovidcatatoniapartiallyrefractorytoivlorazepam
AT hagertyvivian po069acaseofpostcovidcatatoniapartiallyrefractorytoivlorazepam
AT sotelojorge po069acaseofpostcovidcatatoniapartiallyrefractorytoivlorazepam